Version 3.16 was released to production on September 18th 2025. Please do not hesitate to contact our support email support@hdcbc.ca should you have any questions or comments about any of these changes.
What’s New?
Metabolic Syndrome: To support the CHANGE BC program, we have added the following measures related to metabolic syndrome:
| Measures | MOIS | OSCAR | PROFILE | MED ACCESS | MED ACCESS – LEGACY |
| Metabolic syndrome prevalence | NEW | NEW | NEW | NEW | NEW |
| Metabolic syndrome based on diagnostic criteria – two or more | NEW | NEW | NEW | NEW | NEW |
| Metabolic syndrome based on diagnostic criteria – three or more | NEW | NEW | NEW | NEW | NEW |
| Metabolic syndrome based on diagnostic criteria – three or more (not excluding diabetes) | NEW | NEW | NEW | NEW | NEW |
Heart Failure with Reduced Ejection Fraction (HFrEF): We have added the following measures to support QI projects related to HFrEF.
| Measures | MOIS | OSCAR | PROFILE | MED ACCESS | MED ACCESS – LEGACY |
| Heart failure with reduced ejection fraction prevalence | NEW | NEW | NEW | NEW | NEW |
| HFrEF and prescribed three or more of the four foundational medication classes in the past year | NEW | NEW | NEW | NEW | NEW |
Improvements
Top 10 Coded Prevalence: To improve the accuracy of this list we have excluded conditions where there were overlapping definitions. For example, the “depressive disorder prevalence” and “bipolar disorder prevalence” are subsets of “mood disorder prevalence”. The prevalence measures that are included in the Top 10 Coded Prevalence list are:
| Anxiety and phobias prevalence | Diabetes prevalence | Multiple sclerosis prevalence |
| Asthma prevalence | Eating disorders prevalence | Neurodevelopment disorders prevalence |
| Bipolar disorder prevalence | Frailty prevalence | Osteoarthritis prevalence |
| Cardiovascular disease prevalence | Heart failure prevalence | Palliative/end of life prevalence |
| Chronic kidney disease prevalence | Hepatitis C prevalence | Parkinson’s disease prevalence |
| Chronic liver disease prevalence | HIV prevalence | Primarily psychotic disorders prevalence |
| Chronic pain prevalence | Hypertension prevalence | PTSD prevalence |
| COPD prevalence | Hypothyroidism prevalence | Rheumatoid arthritis prevalence |
| Cystic fibrosis prevalence | Inflammatory bowel disease prevalence | Sleep disorders prevalence |
| Dementia and cognitive impairment prevalence | Ischemic cerebrovascular disease prevalence | Substance use disorder prevalence |
| Depressive disorder prevalence | Ischemic heart disease prevalence |
Updates to Conditions Domain: We have added a “Metabolic Syndrome” subdomain to the “Conditions” domain to support the accessibility of this new measure topic.
“Nonbinary or Unspecified” Definition Added: To improve the clarity of our measures that have an “nonbinary or unspecified” option, we have added the following definition to the “Concepts & Logic” section:
“Where nonbinary or unspecified refers to a patient whose sex or gender is not recorded as male or female in the EMR. This includes entries such as T, O, U, X, I, Unknown, Other, or a blank value in the Sex or Gender field.”
Related Measures:
- Active patients – nonbinary or unspecified
- Encounters in the past year – nonbinary or unspecified
- Encounters in the past 3 years – nonbinary or unspecified
Concept Update
To improve the accuracy of our measures, we have made changes to the following concepts:
| Concept | Changes | Impacted Measures |
| Mental Health | Added “Neurodevelopment Disorder” to the conditions included in this concept | OUD and mental health diagnosis |
Note: For more information or questions, please contact support@hdcbc.ca.